ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

4.00 0 (+0.00%) 7/28/2017 3:51pm
Open: N/A Prev Close: 4.00
High: N/A Low: N/A
Volume: 0 Market Cap: N/A
Year High: 10.50 Year Low: 0.01
Stock Technical Analysis
Targets Six months: 5.2560    One year: 6.1390
Supports Support1: 3.3443   Support2: 2.6300
Resistances Resistance1: 4.5000    Resistance2: 5.2560 
Pivot Point 3.0267 
Moving Averages MA(5): 3.2000      MA(20): 2.9695 

MA(100): 3.0173  1     MA(250):  
MACD MACD(12,26): 0.101      Signal(12,26,9): -0.005 
Stochastic Oscillator %K(14,3): 59.700      %D(3): 38.125 
RSI RSI(14): 72.987 
52-Week High: 5.2000  Low: 1.0100  Change(%): -23
Average Volume(K) 3-Month: 229  10-Days: 14
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BULLISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above the upper band by 13.5%; Bollinger Bands are 88.7% wider than normal.The large width of the bands suggest high volatility as compared to TYMI's normal range. The bands have been in this wide range for 1 bars. This is often a sign that the current trend may be ending.


Stock Chart

Top 100 stocks

Stock News
Tyme's SM-88 Demonstrates Prolonged Overall Survival in Metastatic Cancer ...
Thu, 19 Oct 2017 12:22:30 GMT

Tyme Technologies, Inc. Announces the Issuance of Two New Platform Patents
Mon, 14 Aug 2017 12:32:36 GMT

Wed, 02 Aug 2017 23:19:27 GMT

Tyme Technologies, Inc. Announces $8.2 Million Private Placement
Wed, 22 Mar 2017 16:07:30 GMT

Tyme Technologies Inc. (Nasdaq: TYME) to Ring The Nasdaq Stock Market Opening Bell
Mon, 07 Aug 2017 12:36:24 GMT

Tyme Technologies to Present New Clinical Data for Investigational Drug ...
Mon, 22 May 2017 12:31:20 GMT

Tyme Technologies Appoints Healthcare Veteran Paul L. Sturman as Independent ...
Thu, 02 Mar 2017 12:56:15 GMT

Tyme Technologies Advances SM-88 into the Second Stage of its Phase Ib/II ...
Thu, 05 Jan 2017 14:26:15 GMT

Tyme Technologies Announces Hiring of Shabnam Stanicky as Clinical Operations ...
Fri, 06 Jan 2017 13:30:00 GMT

Tyme Technologies Announces Launch of a Pancreatic Research Program with the ...
Tue, 13 Dec 2016 13:30:00 GMT